1. United States Pharmacopeia (USP). Medicare Prescription Drug Benefit Model Guidelines Source Information. Retrieved from: www.nlm.nih.gov.
2. European Pharmacopoeia (Ph. Eur.). 9th edition. Retrieved from: www.EDQM.eu.
3. Zhuk, Yu.M., Vasiuk, S.O., & Keytlin, I.M. (2012). Spektrofotometrychne vyznachennia bisoprololu za reaktsiieiu z tymolovym synim [Spectrophotometric determination of bisoprolol by reaction with thymol blue]. Zaporozhskiy medytsynskiy zhurnal – Zaporozhye Medical Journal, 3 (72), 62-64 [in Russian].
4. Sandip, A., Sonali, P., Lata, K., Byju Thomas, A., Sumitra, J., Avinash, D., … & Mukesh, M. (2007). Spectrophotometric estimation of bisoprolol fumarate in bulk drug and tablets. Int. J. Pharm. Edu. Res., 41, 4, 353-357.
5. Sahu, R., & Patel, V. B. (2006). Simultaneous spectrophotometric estimation of hydrochlorothiazide and bisoprolol fumarate in combined dosage forms. Indian J. Pharm. Sci., 68, 6, 764-767.